Serum copper and vascular endothelial growth factor (VEGF-A) in dysfunctional uterine bleeding

American Journal of Biochemistry and Molecular Biology

Volumn 1, Issue 3, 2011, Pages 284-290

  Rafi, Afshan ^a   Ramakrishna, D ^a   Sabitha, K ^b   Mohanty, S ^a   Rao, Pragna ^c  

^a Kamineni Institute of Medical Sciences ^*  (India)

^b Chalmeda Anand Rao Institute of Medical Sciences   (India)

^c KASTURBA MEDICAL COLLEGE   (India)

Author keywords

Angiogenesis; Dysfunctional uterine bleeding; ELISA; Endometrium; Odds ratio; Serum copper; Vascular endothelial growth factor

Indexed keywords

COPPER; HEMOGLOBIN; VASCULOTROPIN A;

ADOLESCENT; ADULT; ARTICLE; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; COPPER BLOOD LEVEL; ECHOGRAPHY; ENDOMETRIAL THICKNESS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FEMALE GENITAL TRACT PARAMETERS; HUMAN; METRORRHAGIA; NEOVASCULARIZATION (PATHOLOGY); NON INVASIVE MEASUREMENT; PROTEIN BLOOD LEVEL; SENSITIVITY AND SPECIFICITY; SPECTROPHOTOMETRY;

EID: 79955560765     PISSN: 21504210     EISSN: 21504253     Source Type: Journal    
DOI: 10.3923/ajbmb.2011.284.290     Document Type: Article

References (31)

1. Achache, H. and A. Revel, 2006. Endometrial receptivity markers, the journey to successful embryo implantation. Hum. Reprod. Update, 12: 731-746.
2. Al-Numair, K., 2006. Copper and zinc status in healthy volunteers living in Saudi Arabia. J. Medical Sci, 6: 519-527.
3. Almansour, M.I., 2006. Biochemical effects of copper sulfate, after chronic treatment in quail. J. Boil. Sci., 6: 1077-1082.
4. Baiomy, A.A., L.F. Arafa and A.A. Ghanem, 2004. Relationship between vascular endothelial growth factor and interleukin-6 in diabetic retinopathy. Fak. J. Biol. Sci., 7: 1858-1864.
5. Cullinan-Bove, K. and R.D. Koos, 1993. Vascular endothelial growth factor/vascular permeability factor expression in the rat uterus: Rapid stimulation by estrogen correlates with estrogen-induced increases in uterine capillary permeability and growth. Endocrinology, 133: 829-837.
6. Ferenczy, A., 2003. Fathophysiology of endometrial bleeding. Maturitas, 45: 1-14.
7. Ferrara, N., K. Houck, L. Jakeman and D.W. Leung, 1992. Molecular and biological properties of the vascular endothelial growth factor family of proteins. Endocr. Rev., 13: 18-32.
8. Finney, L., S. Mandava, L. Ursos, W. Zhang and D. Rodi, et al, 2007. X-ray fluorescence microscopy reveals large-scale relocalization and extracellular translocation of cellular copper during angiogenesis. Froc. Natl. Acad. Sci. USA., 104: 2247-2252.
9. Folkman, J. and M. Klagsbrun, 1987. Angiogenic factors. Science, 235: 442-447.
10. Fuchs, A.G., R. Mariotto, E.S. de Lustig, 1986. Serum and tissue copper content in two mammary adenocarcinomas with different biological behaviour. Eur. J. Cancer Clin. Oncol., 22: 1347-1352.
11. Garcia-Morales, P., M. Saceda, N. Kenney, N. Kim and D.S. Salomon et al, 1994. Effect of cadmium on estrogen receptor levels and estrogen-induced responses in human breast cancer cells. J. Biol. Chem, 269: 16896-16901.
12. Gerber, G.B., A. Leonard and P. Jacquet 1980. Toxicity, mutagenicity and teratogenicity of lead. Mutat. Res, 76: 115-141.
13. Girling, J.E. and P.A. Rogers, 2005. Recent advances in endometrial angiogenesis research. Angiogenesis, 8: 89-99.
14. Harris, E.D, 2004. A requirement for copper in angiogenesis. Nutr. Rev, 62: 60-64.
15. Herve, M.A, G. Meduri, F.G. Petit, T.S. Domet, G. Lazennec, S. Mourah and M. Perrot-Applanat, 2006. Regulation of the Vascular Endothelial Growth Factor (VEGF) receptor Flk-l/KDR by estradiol through VEGF in uterus. J. Endocrinol, 188: 91-99.
16. Jun, T, Z. Liancai and W. Bochu, 2007. Effects of quercetin on DNA damage induced by copper ion. Int. J. Pharmacol, 3: 19-26.
17. Krizek, M, V. Senft and J. Motan, 1997. Copper and the human body. Cas. Lek. Cesk, 136: 698-701.
18. Kulier, R, F.M. Helmerhorst, P. O'Brien, M. Usher-Patel and C. D'Arcangues, 2006. Copper containing, framed intra-uterine devices for contraception. Cochrane Database Syst. Rev, 19: CD005347-CD005347.
19. Leone, N, D. Courbon, P. Ducimetiere and M. Zureik, 2006. Zinc, copper and magnesium and risks for all-cause cancer and cardiovascular mortality. Epidemiology, 17: 308-314.
20. Margalioth, E.J, J.G. Schenker and M. Chevion, 1983. Copper and zinc levels in normal and malignant tissues. Cancer, 52: 868-872.
21. Martin, M.B, R. Reiter, T. Pham, Y.R. Avellanet and J. Camara et al., 2003. Estrogen-like activity of metals in MCF-7breast cancer cells. Endocrinology, 144: 2425-2436.
22. Mocellin, S, 2006. Tumor vasculature: The achilles heel of cancer. Int. J. Cancer Res, 2: 176-187.
23. Pan, Q, C.G. Kleer, K.L. van Golen, J. Irani and K.M. Bottema et al., 2002. Copper deficiency induced by tetrathiomolybdate suppresses tumor growth and angiogenesis. Cancer Res, 62: 4854-4859.
24. Peraza, M.A, F. Ayala-Fierro, D.S. Barber, E. Casarez and L.T. Rael, 1998. Effects of micronutrients on metal toxicity. Environ. Health Perspect, 10: 203-216.
25. Schwartz, A.E, G.W. Leddicotte, R.W. Fink and E.W. Friedman, 1974. Trace elements in normal and malignant human breast tissue. Surg, 76: 325-329.
26. Sen, C.K, S. Khanna, M. Venojarvi, P. Trikha, E.C. Ellison, T.K. Hunt and S. Roy, 2002. Copper-induced vascular endothelial growth factor expression and wound healing. Am. J. Physiol. Heart Circ. Physiol, 282: H1821-H1827.
27. Smith, S.K, 2001. Angiogenesis and reproduction. BJOG, 108: 777-783.
28. Stoica, A, E. Pentecost and M.B. Martin, 2000. Effects of selenite on estrogen receptor-a expression and activity in MCF-7 breast cancer cells. J. Cell. Biochem, 79: 282-292.
29. Torry, D.S, V.J. Holt, J.A. Keenan, G. Harris, M.R. Caudle and R.J. Torry, 1996. Vascular endothelial growth factor expression in cycling human endometrium. Fertil. Steril, 66: 72-80.
30. Uzych, L, 1985. Teratogenesis and mutagenesis associated with the exposure of human males to lead: A review. Yale J. Biol. Med, 58: 9-17.
31. Yoshii, J, H. Yoshiji, S. Kuriyama, Y. Ikenaka and R. Noguchi et al., 2001. The copper-chelating agent, trientine, suppresses tumor development and angiogenesis in the murine hepatocellular carcinoma cells. Int. J. Cancer, 94: 768-773.